Ottawa Heart Institute Research Corporation
Clinical trials sponsored by Ottawa Heart Institute Research Corporation, explained in plain language.
-
Heart shock showdown: ablation vs. drugs – tiny trial ends early
Disease control TerminatedThis study tested whether a catheter-based procedure (ablation) is better than heart rhythm drugs at preventing painful shocks in people with an implantable defibrillator. Only 3 volunteers took part before the trial was stopped early, so no firm conclusions can be drawn. The goa…
Phase: PHASE4 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Blood thinner after heart procedure fails to prevent artery blockage
Disease control TerminatedThis study tested whether taking rivaroxaban (a blood thinner) for 7 days after a heart catheterization through the wrist could prevent the wrist artery from becoming blocked. About 930 adults were planned, but the study was stopped early. The main goal was to see if the drug red…
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated May 11, 2026 20:48 UTC